DD vs GH · P/E 127, rev $12.39B vs rev $739.0M
Dupont De Nemours Inc (DD) versus Guardant Health Inc (GH) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
DD currently screens at market cap $19.61B and trailing P/E 127.4. GH currently screens at market cap $6.32B.
Not investment advice. Open the DD and GH stock pages for the full models.
Not investment advice.